Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Department of Medicine (2)
- Fellows and Residents (2)
- Infection (2)
- Acquired Hemophilia (1)
- Antiplatelet (1)
-
- COVID-19 (1)
- Cardiovascular (1)
- Chronic Liver Disease (1)
- Department of Medicine Faculty (1)
- Department of Medicine Fellows and Residents (1)
- Emergence of COVID-19 (1)
- Fatal complication (1)
- Global Liver Registry (1)
- Liver (1)
- Mortality (1)
- Mucormycosis (1)
- Patients with diabetes and hyperglycaemia (1)
- Percutaneous (1)
- Review (1)
- SARS-COV-2 (1)
- SARS-CoV2 (1)
Articles 1 - 6 of 6
Full-Text Articles in Medicine and Health Sciences
Cutaneous Manifestations Of Nutritional Deficiencies In The Context Of Food Deserts Of United States., Justin P Canakis, Shane M. Swink Do, Nicholas P Valle, Diana A. Rivers Do, Kristina M. Lim Do, Steven Oberlender Md, Phd, Stephen M. Purcell Do, Cynthia L. Bartus Md
Cutaneous Manifestations Of Nutritional Deficiencies In The Context Of Food Deserts Of United States., Justin P Canakis, Shane M. Swink Do, Nicholas P Valle, Diana A. Rivers Do, Kristina M. Lim Do, Steven Oberlender Md, Phd, Stephen M. Purcell Do, Cynthia L. Bartus Md
Department of Medicine
Food deserts exist due to a multitude of factors ranging from socioeconomic status, racial disparities, geography, cost, and healthful food access. Given the vast biological function of vitamins and minerals, the clinical presentation for nutritional deficiencies ranges from benign to life-threatening. Often, the first indicators of underlying nutritional deficiencies are cutaneous manifestations. The first patient case is a 36-year-old female at 25 weeks gestation with a pruritic and painful rash that began in the genital region and spread centrifugally to her legs. The second patient case is a 42-year-old male with a pruritic rash that began at his abdomen and …
Acquired Hemophilia A: A Possibly Fatal Complication Of Sars-Cov-2 Infection, Hasan Fareed Siddiqui, Taymmia Ejaz, Aisha Fareed Siddiqui, Fahd Niaz Shaikh
Acquired Hemophilia A: A Possibly Fatal Complication Of Sars-Cov-2 Infection, Hasan Fareed Siddiqui, Taymmia Ejaz, Aisha Fareed Siddiqui, Fahd Niaz Shaikh
Department of Medicine
No abstract provided.
The Impact Of The Covid-19 Pandemic On Patients With Chronic Liver Disease: Results From The Global Liver Registry, Zobair M. Younossi, Yusuf Yilmaz, Mohamed El-Kassas, Ajay Duseja, Saeed Hamid, Gamal Esmat, Nahum Méndez-Sánchez, Wah Kheong Chan, Ashwani K. Singal, Brian Lam
The Impact Of The Covid-19 Pandemic On Patients With Chronic Liver Disease: Results From The Global Liver Registry, Zobair M. Younossi, Yusuf Yilmaz, Mohamed El-Kassas, Ajay Duseja, Saeed Hamid, Gamal Esmat, Nahum Méndez-Sánchez, Wah Kheong Chan, Ashwani K. Singal, Brian Lam
Department of Medicine
Patients with preexisting chronic liver disease (CLD) may experience a substantial burden from both coronavirus 2019 (COVID-19) infection and pandemic-related life disruption. We assessed the impact of the COVID-19 pandemic on patients with CLD. Patients enrolled in our Global Liver Registry were invited to complete a COVID-19 survey. As of June 2021, 2500 patients (mean age ± SD, 49 ± 13 years; 53% men) from seven countries completed the survey. Of all survey completers, 9.3% had COVID-19. Of these patients, 19% were hospitalized, 13% needed oxygen support, but none required mechanical ventilation. Of all patients including those not infected with …
Does Individualized Guided Selection Of Antiplatelet Therapy Improve Outcomes After Percutaneous Coronary Intervention? A Systematic Review And Meta-Analysis, Naser Yamani, Samuel Unzek, Muhammad Hasnain Mankani, Talal Almas, Adeena Musheer, Humera Qamar, Shausha Farooq, Waqas Shahnawaz, Kaneez Fatima, Vincent Figueredo
Does Individualized Guided Selection Of Antiplatelet Therapy Improve Outcomes After Percutaneous Coronary Intervention? A Systematic Review And Meta-Analysis, Naser Yamani, Samuel Unzek, Muhammad Hasnain Mankani, Talal Almas, Adeena Musheer, Humera Qamar, Shausha Farooq, Waqas Shahnawaz, Kaneez Fatima, Vincent Figueredo
Department of Medicine
Background: The potential benefits of individualized guided selection of antiplatelet therapy over standard antiplatelet therapy in improving outcomes in patients undergoing percutaneous coronary intervention (PCI) have not been established. Therefore, we pooled evidence from available clinical trials to assess the effectiveness by comparing the two regimens in patients undergoing PCI.
Methods: We queried two electronic databases, MEDLINE and Cochrane CENTRAL, from their inception to April 20, 2021 for published randomized controlled trials in any language that compared guided antiplatelet therapy, using either genetic testing or platelet function testing, versus standard antiplatelet therapy in patients undergoing PCI. The results from trials …
The Emergence Of Covid-19 Associated Mucormycosis: A Review Of Cases From 18 Countries, Martin Hoenigl, Danila Seidel, Agostinho Carvalho, Shivaprakash M. Rudramurthy, Amir Arastehfar, Jean-Pierre Gangneux, Nosheen Nasir, Alexandro Bonifaz, Javier Araiza, Nikolai Klimko
The Emergence Of Covid-19 Associated Mucormycosis: A Review Of Cases From 18 Countries, Martin Hoenigl, Danila Seidel, Agostinho Carvalho, Shivaprakash M. Rudramurthy, Amir Arastehfar, Jean-Pierre Gangneux, Nosheen Nasir, Alexandro Bonifaz, Javier Araiza, Nikolai Klimko
Department of Medicine
Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes and hyperglycaemia often have an inflammatory state that could be potentiated by the activation of antiviral immunity to SARS-CoV2, which might favour secondary infections. In this Review, we analysed 80 published and unpublished cases of COVID-19-associated mucormycosis. Uncontrolled diabetes, as well as systemic corticosteroid treatment, were present in most patients with COVID-19-associated mucormycosis, and rhino-orbital cerebral mucormycosis was the most frequent disease. Mortality was high at 49%, which was particularly due to patients with pulmonary or disseminated mucormycosis or …
Impact Of Delayed Pain To Needle And Variable Door To Needle Time On In-Hospital Complications In Patients With St-Elevation Myocardial Infarction Who Underwent Thrombolysis: A Single-Center Experience., Arshad Muhammad Iqbal, Syed Farrukh Jamal, Adnan Ahmed, Hassan Khan, Waqar Khan, Faisal Ahmed, Ramchandani Santosh Md, Muhammad Salman Ghazni, Ateeq Mubarik, Bashir Hanif
Impact Of Delayed Pain To Needle And Variable Door To Needle Time On In-Hospital Complications In Patients With St-Elevation Myocardial Infarction Who Underwent Thrombolysis: A Single-Center Experience., Arshad Muhammad Iqbal, Syed Farrukh Jamal, Adnan Ahmed, Hassan Khan, Waqar Khan, Faisal Ahmed, Ramchandani Santosh Md, Muhammad Salman Ghazni, Ateeq Mubarik, Bashir Hanif
Department of Medicine
Background Myocardial infarction is a life-threatening event, and timely intervention is essential to improve patient outcomes and mortality. Previous studies have shown that the time to thrombolysis should be less than 30 minutes of the patient's arrival at the emergency room. Pain-to-needle time is a time from onset of chest pain to the initiation of thrombolysis, and door-to-needle time is a time between arrival to the emergency room to initiation of thrombolytic treatment. Ideally, the target for door-to-needle time should be less than 30 minutes; however, it is unclear if the door-to-needle time has a significant impact on patients presenting …